Some studies have suggested that effective and long-term immunotherapy could improve the prognosis of anti-LGI1 encephalitis (9), while the complications of chronic immunotherapy cannot be ignored, as they occurred in approximately one-half of the patients (18). Here, LGI1 is linked to encephalitis.